Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo

por Tang, Shou-Hung, Huang, Hsu-Shan, Wu, Hong-Ui, Tsai, Yi-Ta, Chuang, Mei-Jen, Yu, Cheng-Ping, Huang, Shih-Ming, Sun, Guang-Huan, Chang, Sun-Yran, Hsiao, Pei-Wen, Yu, Dah-Shyong, Cha, Tai-Lung
Publicado 2014

The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation

por Chuang, Mei-Jen, Wu, Sheng-Tang, Tang, Shou-Hung, Lai, Xiang-Me, Lai, Hsiao-Chu, Hsu, Kai-Hsiang, Sun, Kuang-Hui, Sun, Guang-Huan, Chang, Sun-Yran, Yu, Dah-Shyong, Hsiao, Pei-Wen, Huang, Shih-Ming, Cha, Tai-Lung
Publicado 2013